Clinical prognostic factors associated with survival and a survival score for patients with brain metastases

Future Oncol. 2019 Aug;15(22):2619-2634. doi: 10.2217/fon-2019-0119. Epub 2019 Jul 10.

Abstract

Aim: To identify prognostic factors of survival in patients with brain metastases (BM) and to devise a prognostic score. Patients & methods: In this single-institution retrospective study, we analyzed potential clinical prognostic factors in 1363 patients with BM. Based on the Cox proportional hazard model, we devised a BM score with three classes (score <5, 5-6 and >6). Results: The 1-year overall survival (OS) was 26%. Independent prognostic factors of OS were: age, gender, Karnofski performance status, number of BM, control of primary, presence of extracerebral metastases and type of primary tumor. The 1-year OS was 56% for score <5; 21% for score 5-6 and 4% for score >6 (p < 0.01). Conclusion: The BM score we propose is effective in grouping patients according to their prognosis and can help decision making regarding treatment adjustments.

Keywords: brain metastases; prognosis; prognostic score; survival; whole-brain radiotherapy.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms / epidemiology
  • Brain Neoplasms / pathology
  • Brain Neoplasms / radiotherapy*
  • Brain Neoplasms / secondary
  • Child
  • Cranial Irradiation / methods*
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / epidemiology
  • Neoplasms / pathology
  • Neoplasms / radiotherapy*
  • Prognosis*
  • Proportional Hazards Models
  • Risk Factors
  • Young Adult